Home › Funds › ORBIMED ADVISORS LLC › ARGX

ORBIMED ADVISORS LLC position in ARGX

ARGENX SE · Health Care

ORBIMED ADVISORS LLC reported holding 92,880 shares of ARGX (ARGENX SE) in its Q2 2026 13F filing — a position valued at US$86.2M, representing 1.73% of its reported portfolio and ranking #12 among its reported holdings. ORBIMED ADVISORS LLC has disclosed ARGX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)92.88K sh
Reported value held$86.17M
Portfolio Weight1.73%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ORBIMED ADVISORS LLC's ARGX position evolved

ORBIMED ADVISORS LLC first disclosed a stake in ARGX in Q3 2023 at 32,600 shares (US$16.0M). The position peaked in Q3 2025 at 172,300 shares, worth US$127.1M. Across 12 filings, ORBIMED ADVISORS LLC increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 92,880 shares valued at US$86.2M — a reduction of -44,020 shares quarter over quarter.. Notable position changes include a 160% increase in Q4 2023 (shares rose 3% over the following quarter), a 79% increase in Q1 2024 (shares rose 9% over the following quarter), a 38% increase in Q2 2024 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 32.60K $16.03M New
Q4 2023 84.60K $32.18M Add
Q1 2024 151.60K $59.69M Add
Q2 2024 209.10K $89.92M Add
Q3 2024 204.50K $110.86M Reduce
Q4 2024 189.70K $116.67M Reduce
Q1 2025 206.70K $122.34M Add
Q2 2025 208.00K $114.65M Add
Q3 2025 172.30K $127.08M Reduce
Q4 2025 146.00K $122.78M Reduce
Q1 2026 136.90K $99.97M Reduce
Q2 2026 92.88K $86.17M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ARGX and 13F data

ARGX (ARGENX SE) is a Health Care company. 39 other funds we track also report a position in ARGX — the largest reported positions include Jupiter Topco LLC (US$2.30B), Janus Henderson Group (US$1.85B), Artisan Partners Limited Partnership (US$1.40B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ARGX

All ARGX fund holders →

FAQ

How long has ORBIMED ADVISORS LLC held ARGX?

ORBIMED ADVISORS LLC has disclosed ARGX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is ORBIMED ADVISORS LLC's current position in ARGX?

As of Q2 2026, ORBIMED ADVISORS LLC holds 92.88K shares of ARGX (ARGENX SE), valued at $86.17M, representing 1.73% of its reported portfolio and ranking #12.

Has ORBIMED ADVISORS LLC been buying or selling ARGX?

In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC reduced its position in ARGX. The position peaked in Q3 2025 at 172.30K shares.

Which other funds hold ARGX?

Other major institutional holders of ARGX include Jupiter Topco LLC, Janus Henderson Group, Artisan Partners Limited Partnership, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.